Who benefits from direct-to-consumer pharmaceutical advertising?

A new study co-authored by a University of Massachusetts Amherst economist reveals the value of government vaccine recommendations to drugmakers, as well as potential benefits of advertising pharmaceuticals directly to consumers—a practice that is banned in every country apart from the United States and New Zealand.

Leave A Comment

Your email address will not be published. Required fields are marked *